Loblaws reported solid fiscal 2024 results with full-year revenue reaching $61 billion (up 2.5%) and adjusted earnings exceeding $2.6 billion. For the fourth quarter, revenue grew 2.9% to $14.9 billion, and adjusted diluted EPS increased 10% to $2.20, driven by strong market share gains in food and growth in pharmacy services. The company highlighted 'best full-year food market share growth in more than a decade,' fueled by the expansion of its hard discount network and robust digital engagement (online sales up 18.4%). Despite a 14.6% decrease in GAAP net earnings due to a non-cash PC Optimum liability charge, operational momentum remains strong. Looking ahead to 2025, management forecasts high single-digit adjusted EPS growth (excluding a 2% benefit from an extra week) and plans to invest $2.2 billion in capital, including opening approximately 80 new stores, while continuing to return significant capital to shareholders through dividends and buybacks.
| Metric | Value | Change |
|---|---|---|
| Q4 Revenue | $14.9 billion | +2.9% |
| FY 2024 Revenue | $61 billion | +2.5% |
| Q4 Adjusted Diluted EPS | $2.20 | +10% |
| FY 2024 Adjusted EPS Growth | 10.3% | N/A |
| Q4 Adjusted EBITDA | $1.7 billion | +4% |
| Q4 Same-Store Sales (Food, Adjusted) | 2.0% | N/A |
| Online Sales Growth (Q4) | 18.4% | N/A |
| Dividend Growth | 13.9% | N/A |
| Share Repurchases (FY 2024) | $1.8 billion | N/A |
Loblaws is aggressively pivoting toward hard discount formats to capture value-seeking consumers, a strategy yielding significant market share gains. Management reported 'double-digit growth in absolute sales across our discount network' and noted that 'hard discount is still gaining tonnage market share.' The conversion of stores to the Maxi banner in Quebec and the addition of new No Frills locations are directly responding to the consumer shift, with the company planning to add 50 more hard discount stores in 2025. This strategic realignment protects market share against competitors and aligns the cost structure with current consumer spending habits.
The company is leveraging its pharmacy and healthcare assets as a key differentiator and growth engine. Prescription and healthcare services grew same-store sales by 6.3%, driven by expanded scopes of practice for pharmacists. Management highlighted that 'our pharmacists provided 3.1 million prescribing services,' and they plan to build over 250 in-store care clinics. This transforms Shoppers Drug Mart from a retailer into a primary care destination, increasing customer stickiness and utilizing physical real estate for high-margin services that are less susceptible to e-commerce disruption.
Digital engagement is becoming a central pillar of the value proposition, driving both sales and loyalty. Online sales increased by 18.4% in Q4, and the PC Optimum program shows high engagement, evidenced by the recent liability charge due to increased redemption rates. New features like 'Swap and Save' and 'Swap to Canadian' are not just digital tools but strategic levers to influence purchasing behavior in real-time. Management noted a '75% week on week' increase in customers tapping the Canadian product feature, demonstrating the platform's agility in responding to macro events like tariff threats.
Loblaws is executing a strategic expansion into the US market with its TNT banner, signaling a new growth vector. The first TNT supermarket in Seattle is described as 'outperforming every store in our network' and setting 'a new sales record.' While currently a small pilot (planned 7 stores), the success provides a proof-of-concept for international growth. Additionally, the opening of a massive 1.2 million square foot automated distribution center in East Gwillimbury signals a long-term commitment to supply chain efficiency and margin improvement through automation.
Significant macroeconomic headwinds are pressuring margins, specifically the weakening Canadian dollar and potential US tariffs. The CAD is trading at 'the lowest level in over 20 years' (70 cents US), adding inflationary pressure on imports. Management noted that 'less than 10% of our COGS' is exposed to US imports, but this is concentrated in produce, where mitigation is difficult. Furthermore, 'larger global vendors' are requesting 'double-digit price increases,' which management is resisting. These factors threaten to erode the purchasing power of Canadian consumers and compress gross margins if costs cannot be passed on.
The Shoppers Drug Mart front store faces structural and operational challenges that are impacting revenue. The decision to exit low-margin electronics categories will create a '1% impact on front store sales in 2025,' representing a deliberate top-line sacrifice for better margin quality. Additionally, the Canada Post strike had a tangible negative impact, with management noting it 'shut' traffic and sales performance in over 800 outlets. While these issues are being managed, they highlight the vulnerability of the front store model to external disruptions and the difficulty of replacing lost categories.
The company recorded a non-cash charge of $129 million related to the revaluation of the PC Optimum program liability. While management frames this as a result of the program's success ('higher redemption rates'), it represents an increasing cost of customer retention. As redemption rates rise, the future effective cost of the loyalty program increases, potentially limiting the flexibility to use PC Optimum as a lever to drive sales without impacting profitability. This requires careful calibration of the rewards structure to maintain engagement without ballooning liabilities.
Rapid store expansion and the ramp-up of the new automated distribution center present execution risks and short-term margin drag. Management explicitly stated that the new DC and store openings would cause a 'slight deterioration in SG&A rate' in 2025. While the long-term goal is efficiency, the transition period involves significant capital expenditure ($2.2 billion planned) and operational complexity. Any delays in the DC ramp-up or slower-than-expected new store maturation could hinder the achievement of the 'high single-digit' EPS growth guidance.
Overall: Management exhibited a confident and pragmatic demeanor throughout the call, emphasizing 'retail excellence' and disciplined execution. While acknowledging macroeconomic headwinds such as currency fluctuations and potential tariffs, their tone remained optimistic regarding the company's strategic positioning and ability to drive market share. The shift from prepared remarks to Q&A was seamless, with executives providing detailed, data-backed responses that reinforced their control over the business narrative.
Confidence: HIGH - Management provided specific guidance for 2025, detailed mitigation strategies for tariffs, and cited concrete metrics like market share gains and new store performance. The specificity of their responses regarding the DC ramp-up and US expansion indicates strong internal visibility and conviction in their growth plans.
High single digits (excluding ~2% benefit from 53rd week)
~$2.2 billion
Approximately 80 stores (50 hard discount, 30 Shoppers Drug Mart, 2 TNT)
Less than 2%
Slight increase expected
Very slight deterioration due to new DC and stores
Hedging & Uncertainty: Management generally used direct language regarding past performance ('We delivered improving sales momentum') but employed more conditional phrasing when discussing forward-looking macro factors. Phrases like 'if tariffs are applied,' 'we expect to have,' and 'we plan to' were standard. However, when discussing mitigation strategies for tariffs, the language was assertive: 'We have a very, very detailed plan on how to mitigate it.' There was a notable lack of hedging regarding the competitive environment, with Richard Dufrin stating, 'The market continues to be rational,' showing confidence in sector stability. The use of 'we estimate' regarding the 53rd week impact suggests a calculated approach to guidance rather than uncertainty.
"Best full-year food market share growth in more than a decade." - Perbank, President and CEO
"We're seeing these tariffs as a kind of a tax on product that will hurt consumers." - Perbank, President and CEO
"Our internal inflation rate was much lower than CPI." - Richard Dufrin, Chief Financial Officer
"We plan to return most of our free cash flow to shareholders through dividends and share buybacks." - Richard Dufrin, Chief Financial Officer
"The market continues to be rational." - Richard Dufrin, Chief Financial Officer
"We're just overwhelmed with the success that Shenay Lee and the team are having in the US." - Perbank, President and CEO
"We have put that money to work, feeding almost a million children in our local schools." - Perbank, President and CEO
Analyst Sentiment: Analysts were inquisitive and focused on the sustainability of growth amidst macro headwinds. Questions ranged from the mechanics of the US expansion and tariff mitigation to the specific cadence of new store ramp-up and the health of the Canadian consumer. There was a clear interest in understanding how the 'value' narrative would play out against rising vendor costs and currency weakness.
Management Responses: Management responses were detailed and defensive in a constructive manner, often using data to refute concerns. They confidently pushed back on the idea that population growth was necessary for store expansion, citing 'white spots' in the market. They were transparent about the impacts of the Canada Post strike and the electronics exit, providing context that framed these as manageable items rather than systemic failures.
Tariffs and Supply Chain: Analysts pressed for details on US exposure and mitigation. Management emphasized their strong private label portfolio ('no name', 'PC') as a hedge against tariffs on national brands.
Store Expansion Strategy: Questions focused on the sustainability of opening 80 stores annually. Management clarified that many are small formats (8k-10k sq ft) with high returns and distinct trade areas, minimizing cannibalization.
Shoppers Drug Mart Turnaround: Analysts asked about the exit of electronics and the shift to value. Management highlighted the success of lower food prices and the resilience of the pharmacy business.
Inflation and Pricing: Discussion centered on the gap between CPI and internal inflation (LPI). Management noted they are absorbing some costs and pushing back on vendor increases to protect volume.
Loblaws is demonstrating exceptional operational resilience and strategic agility in a challenging macro environment. The company's 'Controlled Choice' strategy—emphasizing hard discount growth, healthcare integration, and digital engagement—is driving market share gains ('best in a decade') and robust EPS growth despite low inflation. The significant investment in supply chain automation (East Gwillimbury DC) and the successful pilot of US expansion (TNT) provide multiple levers for long-term value creation. While headwinds from a weak Canadian dollar and potential tariffs pose risks to margins, management's proven ability to mitigate costs and shift consumer behavior toward private labels offers a strong defensive moat. The commitment to returning capital via dividends and buybacks, combined with a clear growth roadmap, makes Loblaws a compelling holding for stability and growth.
The Canadian dollar is trading at its lowest level in over 20 years (70 cents US), acting as a significant inflationary driver for imported goods, particularly fresh produce. Management noted this adds pressure at a time when consumers are already stressed.
Potential US tariffs are viewed as a 'tax on product' that would hurt consumers. However, Loblaws sees a strategic opportunity to shift volume to its control brands (produced in Canada) if tariffs make US goods uncompetitive.
Consumers remain stressed by affordability, leading to a continued shift toward discount offerings and private labels. However, 'buying Canadian' sentiment is rising rapidly, with Loblaws seeing a 10% uplift in Canadian product sales as consumers actively seek domestic alternatives.